In the third quarter, we also reported our first full quarter of cost of goods for product sales, with a gross profit margin of 92%, which is similar to a branded pharmaceutical product along with a clear value proposition for hospital systems to save money using Quellimmune. We believe this affords us an opportunity to generate future cash, reducing the amount of cash we need to raise to fund operations. Now turning our efforts on the neutralized AKI trial, we completed the interim analysis enabling us to ...

SeaStar Medical Holding (ICU) Q1 2025 Earnings Call May 14, 2025 04:30 PM ET Speaker0 Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the SeaStar Medical First Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to turn the call over to Jackie K ...